Our findings revealed a simultaneous presence of mitophagy and lysosome markers, indicating a clear rise in the joint presence of LC3 and LAMP2 in ovarian cancer with reduced ITGB2 levels, while PI3K/AKT up-regulation could save this pathological change (Figure 5A, 5B). The gene discussed is MAP1LC3A; the disease is ovarian cancer.